Table 3.
Effects of different treatments on PTPase activities on different tissues in rats.
| Parameters | Treatments |
||||
|---|---|---|---|---|---|
| NC | DC | PC | HCO | LCO | |
| Liver (%) | 100.0 ± 3.0B | 129.3 ± 8.9A | 129.2 ± 3.4A | 100.9 ± 8.7B | 104.4 ± 3.4AB |
| Muscle (%) | 100.0 ± 3.3B | 117.8 ± 7.8A | 104.0 ± 1.7AB | 97.6 ± 3.4B | 108.5 ± 1.2AB |
| Perirenal fat (%) | 100.0 ± 6.7A | 94.9 ± 4.0A | 102.6 ± 5.8A | 84.8 ± 2.3A | 87.8 ± 3.7A |
| Epididymal fat (%) | 100.0 ± 8.8B | 160.4 ± 25.7A | 123.2 ± 5.9AB | 96.2 ± 3.0B | 89.0 ± 4.5B |
Results are mean ± SE (n = 6–7). Different letters (A-B) are significantly different (p < 0.05, one-way ANOVA) according to the Tukey’s test. PTPase: Protein tyrosine phosphatase, NC: normal control, DC: diabetic control, PC: 30 mg/kg of pioglitazone, HCO: high-dosage C. obtusa var. formosana leaf extracts, LCO: low-dosage C. obtusa var. formosana leaf extracts.